Safety and efficacy of reduced-intensity myeloablative conditioning regimen with fludarabine and intravenous busulfan for hematological malignancies
Latest Information Update: 12 May 2016
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 29 Oct 2011 New trial record